Feature Articles - BioPharm International

ADVERTISEMENT

Feature Articles

Dilution-Free Protein Concentration Measurement by Absorbance at 280 nm for High Protein Concentration Samples

February 1, 2014

Accurate protein concentration results can be obtained using standard spectrophotometers and commercially available short path length absorption cells.

2014 Manufacturing Trends and Outlook

January 1, 2014

Single-use systems and other technologies drive process efficiencies, but there is room for improvement.

Challenges and Strategies for the Downstream Purification and Formulation of Fab Antibody Fragments

January 1, 2014

Antibody fragments pose unique challenges in recovery, purification, and formulation.

Determining Criticality—Process Parameters and Quality Attributes Part II; Design of Experiments and Data-Driven Criticality

January 1, 2014

Criticality is used as a risk-based tool to drive control strategies.

Innovation and Market Growth in Brazil

January 1, 2014

Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator.

Biopharmaceutical Innovation Updates and Strategies

December 19, 2013

View the business side of biopharmaceuticals: strategies to fund R&D, protect patents, and manage change.

Determining Criticality-Process Parameters and Quality Attributes Part I: Criticality as a Continuum

December 1, 2013

Criticality is used as a risk-based tool to drive control strategies.

Implementing QbD in Sterile Manufacturing

December 1, 2013

Wolfgang Weikmann of Vetter Pharma discusses the implementation of quality by design in sterile manufacturing.

Comparing Protein A Resins for Monoclonal Antibody Purification

December 1, 2013

A prototype Protein A resin is evaluated for purification performance, reusability, and cost performance.

ADVERTISEMENT

ADVERTISEMENT

Click here